tiprankstipranks
Advertisement
Advertisement
Video: Deals in food and pharmaceuticals headline busy morning of M&A
PremiumThe FlyVideo: Deals in food and pharmaceuticals headline busy morning of M&A
2M ago
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
Premium
Ratings
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
2M ago
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
Premium
Ratings
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
2M ago
PepGen reports ‘promising’ topline results from MAD cohort
PremiumThe FlyPepGen reports ‘promising’ topline results from MAD cohort
2M ago
PepGen Inc trading halted, news pending
Premium
The Fly
PepGen Inc trading halted, news pending
2M ago
Midday Fly By: Stocks tumble as oil prices climb again
Premium
The Fly
Midday Fly By: Stocks tumble as oil prices climb again
3M ago
PepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial
PremiumCompany AnnouncementsPepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial
3M ago
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1
Premium
The Fly
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1
3M ago
PepGen reports Q4 EPS (27c), consensus (39c)
Premium
The Fly
PepGen reports Q4 EPS (27c), consensus (39c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100